Abou-Setta AM

No ORCID on file · 8 papers in corpus · active 2006-2020

Study types

  • other 2
  • article 1
  • review 1

Condition tags

  • endometriosis 4
  • dysmenorrhea 2
  • infertility 1
  • endometrioma 1
  • adenomyosis 1
2020
Standardizing definitions and reporting guidelines for the infertility core outcome set: an international consensus development study†  ‡.
Human reproduction (Oxford, England) ·doi:10.1093/humrep/deaa243

Study questionCan consensus definitions for the core outcome set for infertility be identified in order to recommend a standardized approach to reporting?Summary answerConsensus definitions for individual core outcomes, contextual statement…

review 2019
Long-term GnRH agonist therapy before in vitro fertilisation (IVF) for improving fertility outcomes in women with endometriosis
The Cochrane database of systematic reviews ·doi:10.1002/14651858.cd013240.pub2

BACKGROUND: Endometriosis is known to have an impact on fertility and it is common for women affected by endometriosis to require fertility treatments, including in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI), to im…

2018
Application of seminal plasma to female genital tract prior to embryo transfer in assisted reproductive technology cycles (IVF, ICSI and frozen embryo transfer).
The Cochrane database of systematic reviews ·doi:10.1002/14651858.cd011809.pub2

BackgroundThe female genital tract is not exposed to seminal plasma during standard assisted reproductive technology (ART) cycles. However, it is thought that the inflammatory reaction triggered by seminal plasma may be beneficial by induci…

2016
Recombinant versus urinary human chorionic gonadotrophin for final oocyte maturation triggering in IVF and ICSI cycles.
The Cochrane database of systematic reviews ·doi:10.1002/14651858.cd003719.pub4

BackgroundFor the last few decades urinary human chorionic gonadotrophin (uhCG) has been used to trigger final oocyte maturation in cycles of in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI). Recombinant technology h…

2013
Gonadotrophins for idiopathic male factor subfertility.
The Cochrane database of systematic reviews ·doi:10.1002/14651858.cd005071.pub4

BackgroundMale factors leading to subfertility account for at least half of all cases of subfertility worldwide. Although some causes of male subfertility are treatable, treatment of idiopathic male factor subfertility remains empirical. Re…

article 2013
Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery
The Cochrane database of systematic reviews ·doi:10.1002/14651858.cd005072.pub3

BACKGROUND: Various options exist for treating endometriosis, including surgical, medical, such as ovarian suppression, or a combination of these strategies. Surgical treatment of endometriosis aims to remove visible areas of endometriosis.…

other 2013
Role of the levonorgestrel intrauterine system in effective contraception
Patient preference and adherence ·doi:10.2147/PPA.S36948

Norgestrel, a synthetic progestin chemically derived from 19-nortestosterone, is six times more potent than progesterone, with variable binding affinity to various steroid receptors. The levonorgestrel-releasing intrauterine system (LNG IUS…

other 2006
Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery
The Cochrane database of systematic reviews ·doi:10.1002/14651858.CD005072.pub2

BACKGROUND: Various options exist for treating endometriosis, including ovarian suppression therapy, surgical treatment or a combination of these strategies. Surgical treatment of endometriosis sets out to remove visible areas of endometrio…